Varian Medical Systems Supports Program to Tap Brain Power of Research and
Development Community in Russia
MOSCOW, Feb. 11, 2013
MOSCOW, Feb. 11,2013 /PRNewswire/ --Varian Medical Systems (NYSE: VAR), the
world leader in radiotherapy and radiosurgery, is working with key development
agencies in Russia to encourage the country's leading research institutes and
scientists to collaborate on research and development proposals for programs
aimed at advancing radiotherapy technology.
"The leading technologists within Varian have defined five future development
opportunities and will entertain research proposals that address these
challenges from scientists in Russia's R&D community," says Scott Johnson,
Varian's senior manager of research collaborations, who is coordinating
Varian's support for the project. "This is a new type of process for Varian
and we are looking forward to supporting forward-thinking, next-generation
research that could well be developed and commercialized."
Varian has contributed $50,000 to this venture, which will be combined with
other funds equaling $100K in prize money for the team or teams with the best
The program presents the Russian R&D community with the opportunity to take a
focused look at the needs of radiotherapy. "We believe this will yield
significant benefits to cancer patients not only in Russia but throughout the
world. Russia was the first country to put a man into space and it has a deep,
sophisticated technological base in radiation technologies," Johnson says.
The topics specified by Varian technologists include new solutions for
treatment planning, new technologies in brachytherapy, new ways of detecting
targets on computed tomography and magnetic resonance images, designs for
compact and low cost proton accelerators, and new target materials and designs
for converting electron beams to megavoltage X-ray beams.
The program, which runs over the next six months, is also receiving support
from the Skolkovo Foundation, a not-for-profit, government-funded organization
that was launched in 2010 as part of the Kremlin's efforts to create an
innovation ecosystem that is intended as Russia's answer to Silicon Valley.
Varian will assess R&D proposals with the Skolkovo Foundation,and the Rusnano
Foundation for Infrastructure and Educational Programs (FIEP), which develops
and supports Russia's integration with global leaders.
"Varian is the international leader in radiotherapy with centers of excellence
all over the world," says Dow Wilson, chief executive officer of Varian. "With
this innovative program we are engaging the strengths of the Russian R&D
community that can be brought to this network for the benefit of cancer
Varian in Russian Federation
More than 30 Varian medical linear accelerators are installed in Russian
cancer clinics and the company currently supplies up to 20 new treatment
systems each year to radiotherapy departments in the country.
Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading
manufacturer of medical devices and software for treating cancer and other
medical conditions with radiotherapy, radiosurgery, and brachytherapy. The
company supplies informatics software for managing comprehensive cancer
clinics, radiotherapy centers and medical oncology practices. Varian is a
premier supplier of tubes, digital detectors, and image processing
workstations for X-ray imaging in medical, scientific, and industrial
applications and also supplies high-energy X-ray devices for cargo screening
and non-destructive testing applications. Varian Medical Systems employs
approximately 6,200 people who are located at manufacturing sites in North
America, Europe, and China and approximately 70 sales and support offices
around the world. For more information, visit http://www.varian.com or follow
us on Twitter.
SOURCE Varian Medical Systems
Press spacebar to pause and continue. Press esc to stop.